EY
Fraud Investigation & Dispute Services, Life Sciences team

Tighter competition, regulatory scrutiny and tough enforcement heighten the risk of litigation and non-compliance. In your industry, compliance issues and risk factors need to be addressed at every turn from research and development to marketing strategies and supply chain integrity. And the scrutiny of regulators and customers alike is increasing and rapidly changing.

Our professionals understand the complex issues facing pharmaceutical, biotechnology and medical device companies. We have significant experience helping companies evaluate and manage those aspects of their businesses that pose the greatest potential risks. Our dedicated team includes CPAs, government contract analysts, economists, licensed pharmacists and certified fraud examiners, as well as former pharmaceutical executives, ethics and compliance officers and government auditors, investigators and prosecutors.

For more information visit www.ey.com or contact Ted Acosta, Principal, Fraud Investigation & Dispute Services (212) 773-3022, or Mariusz Witalis, Partner, Fraud Investigation & Dispute Services +48 22 557 7950.

PwC Global Pharmaceuticals and Life Sciences Industry Group
The Global Pharmaceuticals and Life Sciences Industry Group at PwC is dedicated to delivering effective solutions to the complex business challenges facing pharmaceutical and life sciences companies. A global leader in serving the pharmaceutical and life sciences industry, PwC has extensive experience working with companies on industry-specific strategic, operational, and financial issues. Our capabilities include assurance, tax and advisory services, as well as industry specialised services in regulatory compliance, risk management, and transaction support. In helping our clients, we draw on the full knowledge and skills of PwC's professionals. More than 208,000 people in 157 countries connect their thinking, experience and solutions to build public trust and enhance value for clients and their stakeholders.

For more information, visit www.pwc.com/pharma.

Baker & McKenzie
Our lawyers have acted as trusted advisers to some of the world's largest pharmaceutical and healthcare companies for more than half a century. Among the first firms to provide comprehensive industry advice -- covering pharmaceuticals, medical devices, healthcare, biotechnology and animal sciences -- we have broad experience and a sophisticated understanding of the global pharmaceutical market that few can match. We help clients soundly navigate intensifying legal and commercial risks, realize opportunities for expansion and growth, and stay ahead of the innovation curve.

Our international network spans 47 countries, including 10 of the largest pharmaceutical markets in the world. Many of our practices -- including Regulatory, Compliance, Intellectual Property, Dispute Resolution, M&A, Tax and Employment -- are ranked among the world's leading, and we bring to bear strong legal capabilities and industry knowledge. For more information www.BakerMcKenzie.com.

Davis Wright Tremaine
Those of us in the Davis Wright Tremaine health care practice group devote nearly all of our time to industry-specific matters. This allows us to develop niche practices within the field that serve needs unique to the health care market. We also understand the business issues and regulatory developments that affect health care delivery and compliance, and as a unified team we can match the attorney with the niche expertise that best addresses client needs. For more information visit our website at www.DWT.com.

Hogan Lovells
Hogan Lovells is a global legal practice that helps corporations, financial institutions, and governmental entities across the spectrum of their critical business and legal issues globally and locally. We have over 2,500 lawyers operating out of more than 45 offices in the United States, Europe, Latin America, the Middle East, Africa, Australia and Asia. With more than 100 lawyers serving the pharmaceutical and biotechnology sectors, including many with experience at the FDA, CMS and other key agencies and in industry, and others holding advanced degrees in relevant disciplines, we offer timely, effective counsel on matters that include product development, approval and post-approval compliance, and the development of next-generation products. High rankings in Chambers, Legal 500, and other global directories speak to the quality and impact of our services.

Whether your products are traditional drugs or biotechnology products, we work with you to successfully develop and commercialize products, addressing issues of regulatory approvals and compliance; coverage, reimbursement, and pricing; and careful use of intellectual property and regulatory exclusivities to manage product life cycles. Our multidisciplinary team leverages the skills and experience of colleagues in other disciplines - including healthcare compliance (such as coverage, reimbursement, pricing, and fraud and abuse prevention), public policy, intellectual property, corporate and securities law, and litigation - to provide integrated, strategic, and practical advice for successful product development and marketing and effective responses to regulators and competitors.

For more information, visit www.hoganlovells.com.

King & Spalding
Celebrating more than 130 years of service, King & Spalding is an international law firm that represents a broad array of clients, including half of the Fortune Global 100, with 900 lawyers in 18 offices in the United States, Europe, the Middle East and Asia. The firm has handled matters in over 160 countries on six continents and is consistently recognized for the results it obtains, its uncompromising commitment to quality and its dedication to understanding the business and culture of its clients. King & Spalding was recently named "Law Firm of the Year" for FDA law by U.S. News & World Report and Best Lawyers. Over the years, LMG Life Sciences has repeatedly identified King & Spalding attorneys in its listing of "Life Sciences Stars", both in the U.S. and in Europe.

For more information about our FDA & Life Sciences practice, please visit www.kslaw.com or contact Mark Brown at +1 202 626 5443.

Navigant
Navigant Consulting, Inc. (NYSE: NCI) is a specialized, global professional services firm that helps clients take control of their future. Navigant's professionals apply deep industry knowledge, substantive technical expertise, and an enterprising approach to help clients build, manage and/or protect their business interests. With a focus on markets and clients facing transformational change and significant regulatory or legal pressures, the Firm primarily serves clients in the healthcare, energy and financial services industries. Across a range of advisory, consulting, outsourcing, and technology/analytics services, Navigant's practitioners bring sharp insight that pinpoints opportunities and delivers powerful results. More information about Navigant can be found at navigant.com.

Paul Hastings
Paul Hastings provides innovative compliance and legal solutions to many of the world's top pharmaceutical and life sciences companies, large and small, in markets across Asia, Europe, Latin America, and the United States. We offer a complete portfolio of services to support our clients' complex, often mission-critical needs--from structuring first-of-their-kind transactions, to protecting critical intellectual property, to resolving complicated global anti-corruption enforcement matters, to providing the savvy compliance and legal counsel that keeps business moving forward.

Paul Hastings has grown steadily and strategically along with our clients across global markets in the critical pharmaceutical and life sciences sector. We have a significant and strategic presence across Europe, and were one of the first U.S. law firms to establish a presence in Asia, where we continue to be a leader in the region, and have significantly expanded our support for clients in Brazil and other emerging markets of Latin America.

More information can be found at www.PaulHastings.com.

Polaris
Polaris helps Pharmaceutical, Biotech, and Medical Device Companies to be compliant with laws and regulations globally, providing best in class compliance solutions.

With proven global expertise in providing insightful consulting, strategic business process optimization and technology solutions, Polaris is the world's leader in innovative, end-to-end compliance services for life sciences companies.

For more information visit www.polarismanagement.com or contact our Amsterdam office at +31.20.240.2518.

Porzio Life Sciences, LLC
Porzio Life Sciences, LLC (PorzioLS) provides the life sciences industry with Internet-based products enabling companies to comply with marketing and sales federal and state laws and regulations, as well as, distribution licensing, sampling and a growing body of state life science compliance requirements. PorzioLS provides compliance tools and customized services related to the PDMA, anti-kickback statutes, aggregate spend reporting, OIG and CMS guidances, OPDP promotional violations, False Claims Act and FDA regulations.

Porzio AggregateSpendID®, a best in class aggregate spend system, handles state and federal transparency reporting and dispute resolutions, in addition to sample transparency reporting. This solution streamlines state and federal marketing disclosures by automating the collection and accurate reporting of expenses directed to healthcare practitioners and organizations.

The searchable databases of the Porzio Compliance Digest cover drug and device distribution licensing, transparency legislation, sample and trade product distribution, and trends in government investigations.

The International Life Sciences Transparency Database contains invaluable guidance on ex-US disclosure obligations pertaining to HCP, HCO and PO payments and provides information on laws and codes related to the following: transparency reporting requirements, limitations or prohibitions on financial interactions with healthcare providers and organizations, anti-bribery or anti-corruption, data privacy, and company compliance programs related to interactions with healthcare providers.

Porzio GST is a Provider Management Simplified solution, focused on Global Spend Transparency, with an easy-to-use and configurable interface that enables companies to capture and manage the data elements that are necessary for meeting their reporting obligations in ex-US countries.

We offer a powerful resource network, proven launch plans and clear executable strategies for entering a diverse marketplace with a multitude of different countries, governments, languages, customs and commercial requirements. Strengthen your compliance program today by visiting www.porziolifesciences.com or contacting us 973-538-1690.

Sidley Austin
Sidley Austin LLP is a premier law firm with an internationally recognized life sciences practice, representing start-ups to large pharmaceutical, biotechnology, medical device, dietary supplements and food clients. Many lawyers on our team are acknowledged leaders in regulatory, compliance and enforcement. Sidley consistently ranks among the top firms in Asia, Europe and the U.S. Sidley recently was named one of Law360's "Life Sciences Practice Groups of the Year" and "Health Care Practice Groups of the Year" for 2015. At the inaugural LMG Life Sciences Awards in 2015, Sidley won "Regulatory Firm of the Year" for the third year in a row. We also received top-tier rankings for EU Pharmaceuticals, Biotechnology and Food Law in the 2015 edition of The Legal 500 EMEA. Sidley is recognized for service and responsiveness, having been once named the "Most Recommended Law Firm in the Pharmaceutical Industry" in the BTI Industry Power Rankings.

For more information visit www.Sidley.com or contact Scott Bass, +1 202 736 8684, James Stansel, +1 202 736 8092, and Maurits Lugard, +32 2 504 6417.

Skadden, Arps, Slate, Meagher & Flom LLP
With approximately 1,700 attorneys in 23 offices on five continents, Skadden represents a broad range of clients in all sectors of the health care industry. We advise pharmaceutical and medical technology clients across the areas of transactions, government regulation and investigation, and litigation. Our work has included multibillion-dollar mergers, complex licensing transactions, product liability defenses, intellectual property matters, and regulatory and enforcement challenges. Skadden has assisted many companies in developing and implementing global anti-bribery and anti-corruption compliance programs, and represented numerous companies in related government investigations.

For more information visit www.Skadden.com.

BMI SYSTEM
Through the creation of bespoke solutions for the healthcare industry, BMI SYSTEM is the leader in providing software solutions dedicated to transparency and regulatory compliance. Beyond BMI SYSTEM's extensive experience in the IT sector, the team possesses in-depth knowledge of the healthcare industry, which allows us to deliver best-of-breed business and technical solutions. For more information visit www.BMI-SYSTEM.com.

International Pharmaceutical Congress Advisory Association (IPCAA)
The mission is to ensure the most beneficial outcome for all parties involved in medical congresses, through the development of common and consistent congress policies and through recognised partnerships with medical societies. The organisation is in regular contact with leading policy-making healthcare organisations.

IPCAA is an affiliate member of IFPMA. IPCAA also facilitates and organises platforms for discussion and education of topics amongst relevant meetings industry stakeholders and contributes to improve the understanding of topics such as compliance and transparency. All employees of a member company benefit from information exchange in congress related matters, free participation of IPCAA events and the immense network opportunities.

For more information visit www.ipcaa.org.

Kroll
Kroll is the leading global provider of risk solutions. We specialise in identifying, remediating and monitoring risk across your enterprise. We address each client issue with a unique team tailored to your situation. We serve a global clientele through more than 50 offices across nearly 30 countries. Individually, our 2,000 professionals offer a wide range of specialised skills, while together, we deliver an unrivalled mix of talent and experience in virtually any market. Kroll has helped clients make confident risk management decisions about people, assets, operations, and security through a wide range of investigations, cyber security, due diligence and compliance, physical and operational security, and data and information management services. We serve a global clientele of law firms, financial institutions, corporations, non-profit institutions, government agencies, and individuals. For more information visit www.kroll.com.

Seton Hall Law's Center for Health & Pharmaceutical Law & Policy
Seton Hall Law's Center for Health & Pharmaceutical Law & Policy advances scholarship and recommendations for policy on the varied and complex issues posed by health and pharmaceutical law. As a nationally ranked Health Law program, the Center fosters informed dialogue between policymakers, consumer advocates, the medical profession, and industry in the search for solutions to the ethical, legal, and social questions presented in the health and pharmaceutical arena.

In addition, the Center is a leader in providing healthcare compliance education and training in the U.S., Europe, and Asia-Pacific on national and international mandates that apply to the safety and promotion of drugs and devices. The Center also hosts conferences and educational programs, inviting leading experts from the public and private sectors to examine cutting edge policy issues.

Launched in 2007, the Center extends Seton Hall Law School's national reputation in health law to the life sciences arena and offers a challenging health law curriculum through its M.S.J., J.D., and LL.M. degree programs, online Graduate Certificates, and online M.S.J. The Center operates under the leadership of Assistant Dean Simone Handler-Hutchinson, and draws upon the intellectual strength of the Seton Hall Law School faculty and research fellows who bring to the Center's work nationally-recognized expertise in health and pharmaceutical law, not-for-profit governance, intellectual property law and bioethics, among other areas.

For further information or inquiries about the Center and its varied programs, please visit the website at and law.shu.edu/CenterforHealth and law.shu.edu/compliance.